Why the study?
Does an insertable cardiac monitor improve diagnostic yield in patients with syncope or palpitation?
Observational (n=30)
Does an insertable cardiac monitor improve diagnostic yield in patients with syncope or palpitation?
Insertable cardiac monitors provide a high diagnostic yield (75%) for identifying the etiology of recurrent syncope and detecting arrhythmias over long-term follow-up.
Objective To evaluate the clinical value of the insertable cardiac monitor (ICM) in the field of long-term monitoring. Methods A total of 30 patients with syncope or palpitation from February 2016 to November 2017 were implanted with ICM (Reveal LINQ LNQ11, Medtronic Inc.) . Results During the monitoring period (7.6±3.5) months, a total of 12 patients had recurrent syncope or pre-syncope, the ICM-guided diagnosis rate was 75.0%, of which 66.7% was cardiogenic syncope. Seven patients were found to have atrial tachycardia/atrial fibrillation, of which asymptomatic atrial fibrillation accounted for 28.6%. One patient was diagnosed with paroxysmal supraventricular tachycardia. Conclusion ICM can long-term monitor the cardiac electrical activity and provide evidence for clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2018) conducted an observational in Syncope or palpitation (n=30). Insertable cardiac monitor (ICM) was evaluated on ICM-guided diagnosis rate in patients with recurrent syncope or pre-syncope.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: